Year-over-year earnings per share growth for the last twelve months: trinitybiotech.com (TRIB)
Trinity Biotech plc (TRIB) scales through equipment sales, which secure a steady order flow for high-cost reagents. The quarterly EPS growth rate on GURU.Markets confirms this trend, with the parameter stabilizing at 52.70. Stable demand for consumables guarantees sustainable margins and FCF, while the implementation of portable IT monitoring systems allows the company to expand distribution within the saturated global diagnostics market.
Summary analytical data breakdowns for Trinity Biotech plc (TRIB)
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Capital Trinity Biotech plc|TRIB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity trinitybiotech.com|TRIB - Company Aggregate Debt|Debts to Book Capitalization Trinity Biotech Corp|TRIB - Long-Term Debt Volume|Company Current Liabilities Trinity Biotech|Quick Liquidity Indicator trinitybiotech.com
- earnings and valuation multiples information:
TRIB - Company Net Income|Future Profit Trinity Biotech plc|TRIB - Company Value to Net Income|Forward P/E Multiple trinitybiotech.com|TRIB - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Trinity Biotech Corp|TRIB - Operating income before deduction of amortization|Earnings per share for the last twelve months Trinity Biotech|TRIB - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months trinitybiotech.com|TRIB - Net earnings per one share growth for the current year|Earnings growth forecast for next year Trinity Biotech plc
Summary company analysis:Trinity Biotech PLC - TRIB
Supplies of consumables for global diagnostics allow Trinity Biotech plc (TRIB) to maintain a stable cash flow, yet quarterly EPS progress reveals the actual dynamics of net profit per share. This indicator measures the rate of change in operational efficiency, uncovering hidden imbalances and risks of business deceleration that are often masked by the external stability of market quotes.
Competitors of Trinity Biotech plc (TRIB)
A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RVTY (Revvity, Inc.)|Year-over-year earnings per share growth rate for the last twelve months BIO|Year-over-year earnings per share growth for the last twelve months Anbio NNNN|Year-over-year earnings per one share growth for the last 12 months SHC|QuidelOrtho Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months OPKO Health Corp. OPK|caredx.com (CDNA) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months MRVI|FLGT (Fulgent Genetics) - Quarterly EPS earnings growth|Standard BioTools Inc (LAB) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CTKB (Cytek Bio)|Year-over-year earnings per share growth rate for the last twelve months OSUR|Exagen - Year-over-year net earnings per share growth for the last 12 months|mdxhealth.com (MDXH) - Earnings per share growth in annualized terms for the last twelve months|LUCD: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PRE (Prenetics Global)|IMDX: Quarterly EPS earnings growth|PRPH (ProPhase Labs Corp) - Year-over-year earnings per share growth for the last twelve months|AIMD (Ainos, Inc.) - Quarterly EPS earnings growth|codiagnostics.com (CODX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months HeartSciences (HSCS)|BMRA - Earnings per share growth in annualized terms for the last twelve months|Cardio Diagnostics Holdings - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ONCO (Onconetix Corporation)|Virax Biolabs Group - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months bluejaydx.com|AWH: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Accelerate Diagnostics Inc.|CNTG (CENTOGENE) - Quarterly EPS earnings growth|ENZ: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months FRES (Fresh2 Group Limited)|GENE (gtglabs.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months 23andMe ME|PMD (Psychemedics Corp.) - Year-over-year net earnings per share trend for the last twelve months
